Evidence map›Paper›PMID 35154568›Full record

ArticleOxidative medicine and cellular longevity2022

Luteolin Protects Chondrocytes from H

Zhiqiang Zhou, Linlin Zhang, Yang Liu, Chaoming Huang, Wei Xia, Haibin Zhou, Zhengyu Zhou, Xiaozhong Zhou

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Immunopharmacological Activities of Luteolin in Chronic Diseases.International journal of molecular sciences · 2023
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhiqiang ZhouDepartment of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China.ORCID https://orcid.org/0000-0002-5144-095X
Linlin ZhangDepartment of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Yang LiuDepartment of Pharmaceutics, College of Pharmaceutical Sciences, Soochow University, Suzhou 215000, China.
Chaoming HuangDepartment of Orthopedics, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian 223800, China.
Wei XiaDepartment of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China.
Haibin ZhouDepartment of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China.ORCID https://orcid.org/0000-0002-9051-5942
Zhengyu ZhouLaboratory Animal Center, Medical College of Soochow University, Suzhou 215000, China.ORCID https://orcid.org/0000-0001-5712-9495
Xiaozhong ZhouDepartment of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China.ORCID https://orcid.org/0000-0003-3076-5090
Soochow University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a chronic degenerative disease featured by cartilage erosion and inflammation. Luteolin, a member of the flavonoid family, has been shown to exert anti-inflammatory and antioxidative activities. However, the potential biological effects and underlying mechanism of luteolin on chondrocytes and OA progression remain largely elusive. In this study, the potential effect and mechanism of luteolin on OA were investigated

Indexed as

Disease ProgressionAMP-Activated Protein KinasesAnimalsAntioxidantsApoptosisBiological ProductsCartilage, ArticularCells, CulturedChondrocytesDisease Models, AnimalGene Knockdown TechniquesHydrogen PeroxideLuteolinMaleMAP Kinase Signaling SystemMiceAMP-Activated Protein KinasesAntioxidantsBiological ProductsHydrogen PeroxideLuteolinNfe2l2 protein, mouseNF-E2-Related Factor 2Prkaa1 protein, mouse

Identifiers

PMID35154568
PMCPMC8825676
OpenAlexW4210696303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.